Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilding

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Cancer Surveys|January 1, 1992
The importance of steroid hormones in prostate cancerG Wilding
Cancer Surveys|January 1, 1991
Response of prostate cancer cells to peptide growth factors: transforming growth factor-betaG Wilding
Cancer Surveys|January 1, 1995
Endocrine control of prostate cancerG Wilding
Cancer Investigation|January 1, 1992
Steroid hormone agonists and antagonists in the treatment of cancerR Dreicer, G Wilding
Cancer Research|October 1, 1995
Alteration of glyceraldehyde-3-phosphate dehydrogenase activity and messenger RNA content by androgen in human prostate carcinoma cellsM O Ripple, G Wilding
Urology|April 11, 2001
Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agentsW G Nelson, G Wilding
Seminars in Oncology|December 22, 1999
Drug development in prostate cancerG H Ripple, G Wilding
Drugs & Aging|November 22, 2000
Angiogenesis inhibitors. New agents in cancer therapyC J Ryan, G Wilding
Neurogastroenterology and Motility|March 16, 2012
Variable abnormal physiological motility in the proximal upper gastrointestinal tract in gastroparesisA Lee, G Wilding, B Kuo
The Prostate|January 1, 1993
Effects of suramin on the proliferation of primary epithelial cell cultures derived from normal, benign hyperplastic and cancerous human prostatesJ Mitchen, R Rago, G Wilding
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Cancer Surveys|January 1, 1992
The importance of steroid hormones in prostate cancerG Wilding
Cancer Surveys|January 1, 1991
Response of prostate cancer cells to peptide growth factors: transforming growth factor-betaG Wilding
Cancer Surveys|January 1, 1995
Endocrine control of prostate cancerG Wilding
Cancer Investigation|January 1, 1992
Steroid hormone agonists and antagonists in the treatment of cancerR Dreicer, G Wilding
Cancer Research|October 1, 1995
Alteration of glyceraldehyde-3-phosphate dehydrogenase activity and messenger RNA content by androgen in human prostate carcinoma cellsM O Ripple, G Wilding
Urology|April 11, 2001
Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agentsW G Nelson, G Wilding
Seminars in Oncology|December 22, 1999
Drug development in prostate cancerG H Ripple, G Wilding
Drugs & Aging|November 22, 2000
Angiogenesis inhibitors. New agents in cancer therapyC J Ryan, G Wilding
Neurogastroenterology and Motility|March 16, 2012
Variable abnormal physiological motility in the proximal upper gastrointestinal tract in gastroparesisA Lee, G Wilding, B Kuo
The Prostate|January 1, 1993
Effects of suramin on the proliferation of primary epithelial cell cultures derived from normal, benign hyperplastic and cancerous human prostatesJ Mitchen, R Rago, G Wilding
Pageof 11